Match Performance
Your Performance
53.42% of winner
Place:11 / 12
Match %:53.42%
Match Pts:1952.40
Consistency:Consistent
Avg:52.34%
Std Dev:11.1
Spread:45.6 pts
Hits:508A 199C 25D 14M 1NS
Best:
72.38% (S19)
Worst:
26.79% (S38)
Division Winner
Michal Koronkiewicz
Place:1
Match %:100.00%
Match Pts:3654.66
Consistency:Very Consistent
Avg:97.98%
Std Dev:5.3
Spread:33.6 pts
Hits:655A 85C 5D 1M
Best:
100.00% (S1)
Worst:
66.42% (S22)
20%
60%
100%
You Winner Avg
Performance by Stage Type
By Hit Factor
High HF(Speed)
49.43%
2 stages · 43.54% – 61.20%
Medium HF(Balanced)
52.18%
32 stages · 32.60% – 72.38%
Low HF(Technical)
55.41%
6 stages · 26.79% – 67.38%
By Stage Length
Short(≤12 shots)
51.22%
20 stages · 26.79% – 67.38%
Medium(13-24 shots)
52.44%
15 stages · 38.50% – 72.38%
Long(25+ shots)
53.78%
5 stages · 32.60% – 65.21%
Points by Stage
Stage Results
| Stage | Place | % | HF | Time | Hits | Time Gap | Points Gap | Focus | Splits | Analysis |
|---|---|---|---|---|---|---|---|---|---|---|
Stage 1 Stage 1 Med | 8 | 63.54% | 3.4578 | 14.46 | 8A 3C 1D | +40.52% | -10.71% | - | ||
Stage 2 Stage 2 Med | 11 | 54.36% | 3.7659 | 22.04 | 20A 1C 1M 1NS | +44.05% | -21.70% | - | ||
Stage 3 Stage 3 Med | 9 | 65.21% | 3.8914 | 35.72 | 24A 6C 1D | +43.05% | -6.71% | - | ||
Stage 4 Stage 4 Med | 11 | 49.21% | 2.5819 | 20.14 | 8A 4C | +103.23% | 0.00% | - | ||
Stage 5 Stage 5 Med | 11 | 47.18% | 3.2787 | 34.16 | 20A 4C | +101.18% | -5.08% | - | ||
Stage 6 Stage 6 Low | 11 | 60.62% | 2.7367 | 18.27 | 8A 3C 1D | +37.47% | -16.67% | - | ||
Stage 7 Stage 7 Med | 11 | 54.39% | 3.5032 | 31.40 | 20A 3C 1D | +74.35% | -5.17% | |||
Stage 8 Stage 8 Med | 8 | 55.39% | 3.0710 | 15.63 | 6A 6C | +54.75% | -14.29% | |||
Stage 9 Stage 9 Med | 11 | 40.30% | 2.4943 | 13.23 | 6A 4C 1D 1M | +41.20% | -43.10% | |||
Stage 10 Stage 10 Med | 11 | 50.66% | 2.8777 | 27.80 | 17A 5C 2M | +38.52% | -29.82% | |||
Stage 11 Stage 11 Low | 10 | 59.78% | 2.3297 | 22.32 | 8A 4C | +55.32% | -7.14% | - | ||
Stage 12 Stage 12 Med | 9 | 64.83% | 3.9565 | 35.89 | 23A 9C | +46.01% | -5.33% | - | ||
Stage 13 Stage 13 Med | 11 | 62.50% | 4.4060 | 23.15 | 17A 5C 2D | +43.17% | -10.53% | - | ||
Stage 14 Stage 14 Low | 8 | 66.83% | 3.1033 | 18.69 | 11A 1C | +49.64% | 0.00% | - | ||
Stage 15 Stage 15 Low | 8 | 67.38% | 3.3356 | 14.99 | 7A 5C | +23.68% | -16.67% | - | ||
Stage 16 Stage 16 Med | 10 | 48.83% | 2.7918 | 33.67 | 12A 11C 1D | +78.24% | -12.96% | - | ||
Stage 17 Stage 17 Med | 10 | 43.56% | 2.6861 | 53.61 | 24A 8C | +117.48% | -5.26% | - | ||
Stage 18 Stage 18 Med | 11 | 43.75% | 3.0064 | 13.97 | 5A 5C 2D | +65.52% | -27.59% | - | ||
Stage 19 Stage 19 Med | 7 | 72.38% | 4.5624 | 21.48 | 18A 2C 2D | +23.09% | -10.91% | |||
Stage 20 Stage 20 Med | 8 | 65.04% | 3.7963 | 10.80 | 7A 2C | +40.08% | -8.89% | |||
Stage 21 Stage 21 Med | 11 | 57.42% | 2.9257 | 34.18 | 17A 4C 3D | +55.51% | -10.71% | - | ||
Stage 22 Stage 22 Low | 10 | 49.64% | 2.2360 | 8.05 | 4A 2C 2D 1M | +3.60% | -48.57% | - | ||
Stage 23 Stage 23 Med | 11 | 41.53% | 3.1720 | 23.96 | 15A 7C 2M | +52.51% | -36.67% | - | ||
Stage 24 Stage 24 Med | 12 | 39.76% | 2.4096 | 20.75 | 7A 5C | +132.88% | -7.41% | - | ||
Stage 25 Stage 25 Med | 11 | 53.69% | 3.3592 | 11.61 | 9A 1C 1D 1M | +29.72% | -30.36% | - | ||
Stage 26 Stage 26 Med | 8 | 67.84% | 4.6593 | 22.75 | 18A 5C 1D | +34.70% | -8.62% | - | ||
Stage 27 Stage 27 Med | 11 | 51.06% | 3.1881 | 28.23 | 10A 13C 1D | +49.37% | -23.73% | - | ||
Stage 28 Stage 28 Med | 11 | 39.87% | 2.0425 | 24.48 | 8A 3C 1D | +141.18% | -3.85% | - | ||
Stage 29 Stage 29 Med | 11 | 57.18% | 2.8822 | 35.39 | 16A 7C 1D | +51.17% | -13.56% | - | ||
Stage 30 Stage 30 Med | 10 | 59.31% | 5.4956 | 10.19 | 10A 2C | +62.78% | -3.45% | - | ||
Stage 31 Stage 31 Med | 12 | 33.69% | 2.4009 | 17.91 | 10A 1C 1M | +112.71% | -28.33% | |||
Stage 32 Stage 32 Med | 11 | 38.50% | 3.1595 | 26.27 | 15A 6C 1M | +99.62% | -23.15% | |||
Stage 33 Stage 33 Med | 11 | 32.60% | 2.4558 | 46.42 | 22A 8C 2M | +124.14% | -26.92% | |||
Stage 34 Stage 34 Med | 10 | 43.62% | 3.0266 | 16.52 | 7A 5C | +104.71% | -10.71% | |||
Stage 35 Stage 35 Med | 11 | 48.08% | 2.8197 | 19.86 | 10A 2C | +94.13% | -6.67% | - | ||
Stage 36 Stage 36 Med | 10 | 39.93% | 2.5150 | 36.58 | 11A 12C 1D | +102.10% | -19.30% | - | ||
Stage 37 Stage 37 High | 11 | 43.54% | 5.2393 | 19.85 | 16A 8C | +105.91% | -10.34% | - | ||
Stage 38 Stage 38 Low | 12 | 26.79% | 1.2968 | 13.88 | 4A 6C 2M | +19.97% | -67.86% | - | ||
Stage 39 Stage 39 High | 10 | 61.20% | 7.2289 | 7.47 | 9A 3C | +52.14% | -6.90% | - | ||
Stage 40 Stage 40 Med | 10 | 63.36% | 3.7195 | 35.22 | 21A 8C 2D | +48.73% | -5.76% | - |
Time vs Points Analysis
Time (X) vs Points (Y) across all stages. Left is faster, up is more accurate.